Translating MicroRNAs into Biomarkers: What is New for Pediatric Cancer?

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2016 Apr 18

PMID 27085875

Citations 17

Authors

Ivna Neria Silva Ribamar de Carvalho

Renata Mendes de Freitas

Fernando Regla Vargas

Affiliations

Soon will be listed here.

Abstract

Since their discovery in 2008, cell-free circulating microRNAs have been considered potential biomarkers for various conditions, including pediatric cancer. Diagnosis of pediatric cancer still relies on clinical signs, which sometimes may be non-specific or appear at later stages. Thus, there is a need for a better understanding of molecules that allow a less invasive, early and effective method of cancer diagnosis. Despite the efforts of many researches to set specific miRNAs to be routinely used as diagnostic molecules, no miR has been currently utilized so far. In this study, we review the recent discoveries on circulating miRNAs in blood of patients suffering from the following pediatric cancers: osteosarcoma, rhabdomyosarcoma, Wilms tumor, acute myeloid leukemia, acute lymphocytic leukemia, retinoblastoma and neuroblastoma. We also focus on the roles of circulating miRs in tumorigenesis pathways, the methodological approaches used to detect and quantify circulating miRs, and discuss the challenges in using them routinely as biomarkers for pediatric cancers.

Citing Articles

MiRNA expression as outcome predictor in pediatric AML: systematic evaluation of a new model.

Ellson I, Martorell-Marugan J, Carmona-Saez P, Ramos-Mejia V NPJ Genom Med. 2024; 9(1):40.

PMID: 39107334 PMC: 11303725. DOI: 10.1038/s41525-024-00424-w.

A comprehensive overview of liquid biopsy applications in pediatric solid tumors.

Janssen F, Lak N, Janda C, Kester L, Meister M, Merks J NPJ Precis Oncol. 2024; 8(1):172.

PMID: 39097671 PMC: 11297996. DOI: 10.1038/s41698-024-00657-z.

Circulating microRNA profiles in Wilms tumour (WT): A systematic review and meta-analysis of diagnostic test accuracy.

Benlhachemi S, Abouqal R, Coleman N, Murray M, Khattab M, El Fahime E Noncoding RNA Res. 2023; 8(3):413-425.

PMID: 37305178 PMC: 10247954. DOI: 10.1016/j.ncrna.2023.05.007.

Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma.

Shi K, Zhu X, Wu J, Chen Y, Zhang J, Sun X Bioengineered. 2021; 12(1):5950-5970.

PMID: 34482803 PMC: 8806431. DOI: 10.1080/21655979.2021.1972080.

Information Transfer and Biological Significance of Neoplastic Exosomes in the Tumor Microenvironment of Osteosarcoma.

Pu F, Chen F, Zhang Z, Liu J, Shao Z Onco Targets Ther. 2020; 13:8931-8940.

PMID: 32982285 PMC: 7498481. DOI: 10.2147/OTT.S266835.

References

Li Y, Zhang L, Liu F, Xiang G, Jiang D, Pu X . Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma. Dis Markers. 2015; 2015:893594. PMC: 4357047. DOI: 10.1155/2015/893594. View

Kroh E, Parkin R, Mitchell P, Tewari M . Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010; 50(4):298-301. PMC: 4186708. DOI: 10.1016/j.ymeth.2010.01.032. View

Vickers K, Palmisano B, Shoucri B, Shamburek R, Remaley A . MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13(4):423-33. PMC: 3074610. DOI: 10.1038/ncb2210. View

Yamada N, Tsujimura N, Kumazaki M, Shinohara H, Taniguchi K, Nakagawa Y . Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells. Biochim Biophys Acta. 2014; 1839(11):1256-72. DOI: 10.1016/j.bbagrm.2014.09.002. View

Knudson Jr A . Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971; 68(4):820-3. PMC: 389051. DOI: 10.1073/pnas.68.4.820. View

Miyachi M, Tsuchiya K, Yoshida H, Yagyu S, Kikuchi K, Misawa A . Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun. 2010; 400(1):89-93. DOI: 10.1016/j.bbrc.2010.08.015. View

Lian F, Cui Y, Zhou C, Gao K, Wu L . Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. PLoS One. 2015; 10(3):e0121499. PMC: 4361617. DOI: 10.1371/journal.pone.0121499. View

Becker C, Hammerle-Fickinger A, Riedmaier I, Pfaffl M . mRNA and microRNA quality control for RT-qPCR analysis. Methods. 2010; 50(4):237-43. DOI: 10.1016/j.ymeth.2010.01.010. View

Chen C, Ridzon D, Broomer A, Zhou Z, Lee D, Nguyen J . Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33(20):e179. PMC: 1292995. DOI: 10.1093/nar/gni178. View

10.

Fridman E, Dotan Z, Barshack I, David M, Dov A, Tabak S . Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn. 2010; 12(5):687-96. PMC: 2928434. DOI: 10.2353/jmoldx.2010.090187. View

11.

Swellam M, El-Khazragy N . Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia. Tumour Biol. 2016; 37(8):10571-6. DOI: 10.1007/s13277-016-4948-7. View

12.

Sourvinou I, Markou A, Lianidou E . Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. J Mol Diagn. 2013; 15(6):827-34. DOI: 10.1016/j.jmoldx.2013.07.005. View

13.

Igaz I, Igaz P . Diagnostic Relevance of microRNAs in Other Body Fluids Including Urine, Feces, and Saliva. Exp Suppl. 2015; 106:245-252. DOI: 10.1007/978-3-0348-0955-9_11. View

14.

Mandke P, Wyatt N, Fraser J, Bates B, Berberich S, Markey M . MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS One. 2012; 7(8):e42034. PMC: 3411609. DOI: 10.1371/journal.pone.0042034. View

15.

Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang Y . Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res. 2011; 22(1):107-26. PMC: 3351925. DOI: 10.1038/cr.2011.158. View

16.

Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

17.

Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C . Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg. 2010; 14(7):1170-9. DOI: 10.1007/s11605-010-1202-2. View

18.

Zhang C, Yao C, Li H, Wang G, He X . Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. Int J Clin Exp Pathol. 2014; 7(7):4194-203. PMC: 4129034. View

19.

Hutvagner G, McLachlan J, Pasquinelli A, Balint E, Tuschl T, Zamore P . A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science. 2001; 293(5531):834-8. DOI: 10.1126/science.1062961. View

20.

Li H, Zhang K, Liu L, Ouyang Y, Guo H, Zhang H . MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma. Oncol Lett. 2015; 10(3):1662-1668. PMC: 4533320. DOI: 10.3892/ol.2015.3378. View